Time examines how zinc supplements may help save children worldwide

NewsGuard 100/100 Score

TIME examines the "quiet revolution [now] under way" to treat diarrhea using zinc supplements.  The magazine reports that globally the disease "kills an astonishing 1.6 million children under 5 every year," according to the WHO.

In recent years, "a handful of aid organizations and governments," which include USAID and the Bill & Melinda Gates Foundation, "have begun distributing zinc supplements to villagers in Bangladesh, India, Mali and Pakistan. Several other groups are working with governments in Africa to introduce zinc, which comes both in tablet form and as a syrup," Time reports.

"So far, the small programs have drawn little attention. But their impact has been dramatic," the magazine writes. Compared to oral-rehydration therapy (ORT), "which is extremely effective in replacing fluids and nutrients but offers no quick end to the diarrhea itself … [z]inc pills appear to halt diarrhea in its tracks." In parts of the world, children with diarrhea can now be treated with zinc supplements and ORT for as little as 30 cents.

The article includes information on why researchers theorize the zinc supplements are helping to stop diarrhea, the benefits of ORT-zinc combination therapies and examines how zinc-treatment programs are focusing attention on a disease that "has been ignored for decades" (Walt, 8/17).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals age-specific differences in nasal cells' response to SARS-CoV-2